SCHEMBL14840577

SCHEMBL14840577

O=C(O)N1CC(c2[nH]c(-c3ccc(Cl)cc3)nc2-c2ncccn2)CCC1c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRCP P42785 5/20 0.63
▸ HSD11B1 P28845 2/20 0.37
▸ FFAR2 O15552 1/20 0.36
▸ MAPK13 O15264 3/20 0.36
▸ MAPK12 P53778 3/20 0.36
▸ MAPK11 Q15759 3/20 0.36
▸ MAPK14 Q16539 3/20 0.36
▸ RAF1 P04049 1/20 0.36
▸ GCGR P47871 2/20 0.35
▸ DGAT1 O75907 1/20 0.35
▸ SOAT1 P35610 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ SLC6A9 P48067 1/20 0.34
▸ CPT1A P50416 1/20 0.34
▸ SLC6A7 Q99884 2/20 0.33
▸ TNKS O95271 1/20 0.33
▸ GUSB P08236 1/20 0.33
▸ TNKS2 Q9H2K2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14849784 0.90 PRCP (0.59) PRCPHSD11B1FFAR2MAPK13MAPK12
SCHEMBL14849787 0.90 PRCP (0.59) PRCPHSD11B1FFAR2MAPK13MAPK12
SCHEMBL14849812 0.90 PRCP (0.59) PRCPHSD11B1FFAR2MAPK13MAPK12
SCHEMBL14849808 0.90 PRCP (0.59) PRCPHSD11B1FFAR2MAPK13MAPK12
SCHEMBL16512920 0.84 PRCP (0.49) PRCPMAPK13MAPK12MAPK11MAPK14
SCHEMBL14840859 0.80 PRCP (0.66) PRCPHSD11B1MAPK11MAPK14SLC6A7
SCHEMBL14849783 0.77 PRCP (1.00) PRCPMAPK13MAPK12MAPK11MAPK14
SCHEMBL14849781 0.77 PRCP (1.00) PRCPMAPK13MAPK12MAPK11MAPK14
SCHEMBL14849769 0.76 PRCP (1.00) PRCPTGFBR1
SCHEMBL14849806 0.76 PRCP (1.00) PRCPTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006268-B2 Prolylcarboxypeptidase inhibitors MERCK SHARP & DOHME CORP. (US) 2015-04-14 — — US disclosed
EP-2579873-A1 NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-04-17 — — EP disclosed
US-20130090324-A1 NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS MERCK SHARP & DOHME LLC 2013-04-11 — — US disclosed
WO-2011156246-A1 NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-12-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090324-A1 NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS PRCP, PREP, ENPEP PRCP 1/4885HSD11B1 656/4885FFAR2 3966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback